TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB

Clinical trial NCT00664313 · COMPLETED

Trial details

NCT number: NCT00664313
Sponsor: Centers for Disease Control and Prevention
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multi-drug Resistant Tuberculosis Extensively Drug Resistant Tuberculosis

Start date: 2009-04-01
Primary completion: 2010-09-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.